Drugs / attenuated measles vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00828022 | Mar 2009 → ? | measles, non-small cell lung carcinoma | Soroka University Medical Center | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | attenuated measles vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00828022 ↗ |
| Modality | Vaccine | “live, attenuated measles vaccine” NCT00828022 ↗ |